...
机译:同时玻璃体内地塞米松和AfliBercept用于二次到视网膜静脉闭塞的难治性黄斑水肿
Univ Vita Salute Dept Ophthalmol IRCCS Osped San Raffaele Via Olgettina 60 I-20132 Milan Italy;
Univ Vita Salute Dept Ophthalmol IRCCS Osped San Raffaele Via Olgettina 60 I-20132 Milan Italy;
Univ Vita Salute Dept Ophthalmol IRCCS Osped San Raffaele Via Olgettina 60 I-20132 Milan Italy;
Azienda Osped Monza Ophthalmol Unit Via GB Pergolesi 33 I-20900 Monza Italy;
Univ Vita Salute Dept Ophthalmol IRCCS Osped San Raffaele Via Olgettina 60 I-20132 Milan Italy;
Univ Vita Salute Dept Ophthalmol IRCCS Osped San Raffaele Via Olgettina 60 I-20132 Milan Italy;
Macular edema; Anti-VEGF; Dexamethasone; Aflibercept; Retinal vein occlusion;
机译:同时玻璃体内地塞米松和AfliBercept用于二次到视网膜静脉闭塞的难治性黄斑水肿
机译:地塞米松玻璃体内植入物治疗台湾继发性视网膜静脉阻塞难治性黄斑水肿的疗效和安全性
机译:由于非缺血中心视网膜静脉闭塞,在治疗黄斑水肿治疗黄斑水肿中的短期疗效
机译:患有糖尿病黄斑水肿的眼睛中血管网络的形态基于AfliBercept治疗间隔长度的耐受性因耐受性而变化:初步调查结果
机译:视网膜静脉闭塞患者的视网膜血管血流
机译:地塞米松玻璃体内植入物抢救治疗继发于视网膜分支静脉阻塞的贝伐单抗难治性黄斑水肿
机译:真实研究:术术术术,Ranibizumab和地塞米松,用于分支视网膜静脉闭塞